 | • レポートコード：QYR9ST04957 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、多発性骨髄腫治療の世界市場について調査・分析し、多発性骨髄腫治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（化学療法及びその他薬物、放射線、幹細胞移植、その他支持療法）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の多発性骨髄腫治療市場動向 ・主要企業別マーケットシェア ・多発性骨髄腫治療の種類別市場規模2014-2019 （化学療法及びその他薬物、放射線、幹細胞移植、その他支持療法） ・多発性骨髄腫治療の用途別市場規模2014-2019 （病院、診療所、その他） ・多発性骨髄腫治療の北米市場：主要企業・種類別/用途別市場規模 ・多発性骨髄腫治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・多発性骨髄腫治療の中国市場：主要企業・種類別/用途別市場規模 ・多発性骨髄腫治療の日本国内市場：主要企業・種類別/用途別市場規模 ・多発性骨髄腫治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・多発性骨髄腫治療のインド市場：主要企業・種類別/用途別市場規模 ・多発性骨髄腫治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Janssen Biotech, Inc.、Bristol-Myers Squibb、Novartis AG、Bristol-Myers Squibb Company、Millennium Pharmaceuticals、Celgene Corporation、Kesios Therapeutics Limited、Amgene, Inc.、Genzyme Corporation、Juno Therapeutics） ・多発性骨髄腫治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Multiple Myeloma (MM) is a haematological malignancy considered by the propagation of plasma cells in the bone marrow. The disease is incurable; though over the few years there have been substantial developments in therapy, determined by a greater understanding of pathophysiology. Multiple myeloma is common among men as compared to women and also arises commonly with growing age.In 2018, the global Multiple Myeloma Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Multiple Myeloma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Multiple Myeloma Therapeutics development in United States, Europe and China.
The key players covered in this study
Janssen Biotech, Inc.
Bristol-Myers Squibb
Novartis AG
Bristol-Myers Squibb Company
Millennium Pharmaceuticals
Celgene Corporation
Kesios Therapeutics Limited
Amgene, Inc.
Genzyme Corporation
Juno Therapeutics
Market segment by Type, the product can be split into
Chemotherapy And Other Drugs
Radiation
Stem Cell Transplant
Other Supportive Treatments
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Multiple Myeloma Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Multiple Myeloma Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Multiple Myeloma Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Multiple Myeloma Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy And Other Drugs
1.4.3 Radiation
1.4.4 Stem Cell Transplant
1.4.5 Other Supportive Treatments
1.5 Market by Application
1.5.1 Global Multiple Myeloma Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Multiple Myeloma Therapeutics Market Size
2.2 Multiple Myeloma Therapeutics Growth Trends by Regions
2.2.1 Multiple Myeloma Therapeutics Market Size by Regions (2014-2025)
2.2.2 Multiple Myeloma Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Multiple Myeloma Therapeutics Market Size by Manufacturers
3.1.1 Global Multiple Myeloma Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Multiple Myeloma Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Multiple Myeloma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Multiple Myeloma Therapeutics Key Players Head office and Area Served
3.3 Key Players Multiple Myeloma Therapeutics Product/Solution/Service
3.4 Date of Enter into Multiple Myeloma Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Multiple Myeloma Therapeutics Market Size by Type (2014-2019)
4.2 Global Multiple Myeloma Therapeutics Market Size by Application (2014-2019)
5 United States
5.1 United States Multiple Myeloma Therapeutics Market Size (2014-2019)
5.2 Multiple Myeloma Therapeutics Key Players in United States
5.3 United States Multiple Myeloma Therapeutics Market Size by Type
5.4 United States Multiple Myeloma Therapeutics Market Size by Application
6 Europe
6.1 Europe Multiple Myeloma Therapeutics Market Size (2014-2019)
6.2 Multiple Myeloma Therapeutics Key Players in Europe
6.3 Europe Multiple Myeloma Therapeutics Market Size by Type
6.4 Europe Multiple Myeloma Therapeutics Market Size by Application
7 China
7.1 China Multiple Myeloma Therapeutics Market Size (2014-2019)
7.2 Multiple Myeloma Therapeutics Key Players in China
7.3 China Multiple Myeloma Therapeutics Market Size by Type
7.4 China Multiple Myeloma Therapeutics Market Size by Application
8 Japan
8.1 Japan Multiple Myeloma Therapeutics Market Size (2014-2019)
8.2 Multiple Myeloma Therapeutics Key Players in Japan
8.3 Japan Multiple Myeloma Therapeutics Market Size by Type
8.4 Japan Multiple Myeloma Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Multiple Myeloma Therapeutics Market Size (2014-2019)
9.2 Multiple Myeloma Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Multiple Myeloma Therapeutics Market Size by Type
9.4 Southeast Asia Multiple Myeloma Therapeutics Market Size by Application
10 India
10.1 India Multiple Myeloma Therapeutics Market Size (2014-2019)
10.2 Multiple Myeloma Therapeutics Key Players in India
10.3 India Multiple Myeloma Therapeutics Market Size by Type
10.4 India Multiple Myeloma Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Multiple Myeloma Therapeutics Market Size (2014-2019)
11.2 Multiple Myeloma Therapeutics Key Players in Central & South America
11.3 Central & South America Multiple Myeloma Therapeutics Market Size by Type
11.4 Central & South America Multiple Myeloma Therapeutics Market Size by Application
12 International Players Profiles
12.1 Janssen Biotech, Inc.
12.1.1 Janssen Biotech, Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Multiple Myeloma Therapeutics Introduction
12.1.4 Janssen Biotech, Inc. Revenue in Multiple Myeloma Therapeutics Business (2014-2019)
12.1.5 Janssen Biotech, Inc. Recent Development
12.2 Bristol-Myers Squibb
12.2.1 Bristol-Myers Squibb Company Details
12.2.2 Company Description and Business Overview
12.2.3 Multiple Myeloma Therapeutics Introduction
12.2.4 Bristol-Myers Squibb Revenue in Multiple Myeloma Therapeutics Business (2014-2019)
12.2.5 Bristol-Myers Squibb Recent Development
12.3 Novartis AG
12.3.1 Novartis AG Company Details
12.3.2 Company Description and Business Overview
12.3.3 Multiple Myeloma Therapeutics Introduction
12.3.4 Novartis AG Revenue in Multiple Myeloma Therapeutics Business (2014-2019)
12.3.5 Novartis AG Recent Development
12.4 Bristol-Myers Squibb Company
12.4.1 Bristol-Myers Squibb Company Company Details
12.4.2 Company Description and Business Overview
12.4.3 Multiple Myeloma Therapeutics Introduction
12.4.4 Bristol-Myers Squibb Company Revenue in Multiple Myeloma Therapeutics Business (2014-2019)
12.4.5 Bristol-Myers Squibb Company Recent Development
12.5 Millennium Pharmaceuticals
12.5.1 Millennium Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Multiple Myeloma Therapeutics Introduction
12.5.4 Millennium Pharmaceuticals Revenue in Multiple Myeloma Therapeutics Business (2014-2019)
12.5.5 Millennium Pharmaceuticals Recent Development
12.6 Celgene Corporation
12.6.1 Celgene Corporation Company Details
12.6.2 Company Description and Business Overview
12.6.3 Multiple Myeloma Therapeutics Introduction
12.6.4 Celgene Corporation Revenue in Multiple Myeloma Therapeutics Business (2014-2019)
12.6.5 Celgene Corporation Recent Development
12.7 Kesios Therapeutics Limited
12.7.1 Kesios Therapeutics Limited Company Details
12.7.2 Company Description and Business Overview
12.7.3 Multiple Myeloma Therapeutics Introduction
12.7.4 Kesios Therapeutics Limited Revenue in Multiple Myeloma Therapeutics Business (2014-2019)
12.7.5 Kesios Therapeutics Limited Recent Development
12.8 Amgene, Inc.
12.8.1 Amgene, Inc. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Multiple Myeloma Therapeutics Introduction
12.8.4 Amgene, Inc. Revenue in Multiple Myeloma Therapeutics Business (2014-2019)
12.8.5 Amgene, Inc. Recent Development
12.9 Genzyme Corporation
12.9.1 Genzyme Corporation Company Details
12.9.2 Company Description and Business Overview
12.9.3 Multiple Myeloma Therapeutics Introduction
12.9.4 Genzyme Corporation Revenue in Multiple Myeloma Therapeutics Business (2014-2019)
12.9.5 Genzyme Corporation Recent Development
12.10 Juno Therapeutics
12.10.1 Juno Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Multiple Myeloma Therapeutics Introduction
12.10.4 Juno Therapeutics Revenue in Multiple Myeloma Therapeutics Business (2014-2019)
12.10.5 Juno Therapeutics Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Multiple Myeloma Therapeutics Key Market Segments
Table Key Players Multiple Myeloma Therapeutics Covered
Table Global Multiple Myeloma Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Multiple Myeloma Therapeutics Market Size Market Share by Type 2014-2025
Figure Chemotherapy And Other Drugs Figures
Table Key Players of Chemotherapy And Other Drugs
Figure Radiation Figures
Table Key Players of Radiation
Figure Stem Cell Transplant Figures
Table Key Players of Stem Cell Transplant
Figure Other Supportive Treatments Figures
Table Key Players of Other Supportive Treatments
Table Global Multiple Myeloma Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Multiple Myeloma Therapeutics Report Years Considered
Table Global Multiple Myeloma Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Multiple Myeloma Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Multiple Myeloma Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Multiple Myeloma Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Multiple Myeloma Therapeutics Market Share by Regions 2014-2019
Figure Global Multiple Myeloma Therapeutics Market Share by Regions 2014-2019
Figure Global Multiple Myeloma Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Multiple Myeloma Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Multiple Myeloma Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Multiple Myeloma Therapeutics Market Share by Manufacturers in 2018
Table Global Multiple Myeloma Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Multiple Myeloma Therapeutics Product/Solution/Service
Table Date of Enter into Multiple Myeloma Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Multiple Myeloma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Multiple Myeloma Therapeutics Market Size Share by Type (2014-2019)
Figure Global Multiple Myeloma Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Multiple Myeloma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Multiple Myeloma Therapeutics Market Size Share by Application (2014-2019)
Figure Global Multiple Myeloma Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Multiple Myeloma Therapeutics Revenue Market Share by Application in 2018
Figure United States Multiple Myeloma Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Multiple Myeloma Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Multiple Myeloma Therapeutics Market Share (2018-2019)
Table United States Multiple Myeloma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Multiple Myeloma Therapeutics Market Share by Type (2014-2019)
Table United States Multiple Myeloma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Multiple Myeloma Therapeutics Market Share by Application (2014-2019)
Figure Europe Multiple Myeloma Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Multiple Myeloma Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Multiple Myeloma Therapeutics Market Share (2018-2019)
Table Europe Multiple Myeloma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Multiple Myeloma Therapeutics Market Share by Type (2014-2019)
Table Europe Multiple Myeloma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Multiple Myeloma Therapeutics Market Share by Application (2014-2019)
Figure China Multiple Myeloma Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Multiple Myeloma Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Multiple Myeloma Therapeutics Market Share (2018-2019)
Table China Multiple Myeloma Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Multiple Myeloma Therapeutics Market Share by Type (2014-2019)
Table China Multiple Myeloma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Multiple Myeloma Therapeutics Market Share by Application (2014-2019)
Figure Japan Multiple Myeloma Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Multiple Myeloma Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Multiple Myeloma Therapeutics Market Share (2018-2019)
Table Japan Multiple Myeloma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Multiple Myeloma Therapeutics Market Share by Type (2014-2019)
Table Japan Multiple Myeloma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Multiple Myeloma Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Multiple Myeloma Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Multiple Myeloma Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Multiple Myeloma Therapeutics Market Share (2018-2019)
Table Southeast Asia Multiple Myeloma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Multiple Myeloma Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Multiple Myeloma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Multiple Myeloma Therapeutics Market Share by Application (2014-2019)
Figure India Multiple Myeloma Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Multiple Myeloma Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Multiple Myeloma Therapeutics Market Share (2018-2019)
Table India Multiple Myeloma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Multiple Myeloma Therapeutics Market Share by Type (2014-2019)
Table India Multiple Myeloma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Multiple Myeloma Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Multiple Myeloma Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Multiple Myeloma Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Multiple Myeloma Therapeutics Market Share (2018-2019)
Table Central & South America Multiple Myeloma Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Multiple Myeloma Therapeutics Market Share by Type (2014-2019)
Table Central & South America Multiple Myeloma Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Multiple Myeloma Therapeutics Market Share by Application (2014-2019)
Table Janssen Biotech, Inc. Company Details
Table Janssen Biotech, Inc. Revenue in Multiple Myeloma Therapeutics Business (2014-2019) (Million US$)
Figure Janssen Biotech, Inc. Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2014-2019)
Table Janssen Biotech, Inc. Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Multiple Myeloma Therapeutics Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Multiple Myeloma Therapeutics Business (2014-2019)(Million US$)
Figure Novartis AG Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2014-2019)
Table Novartis AG Recent Development
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Revenue in Multiple Myeloma Therapeutics Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Company Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2014-2019)
Table Bristol-Myers Squibb Company Recent Development
Table Millennium Pharmaceuticals Company Details
Table Millennium Pharmaceuticals Revenue in Multiple Myeloma Therapeutics Business (2014-2019)(Million US$)
Figure Millennium Pharmaceuticals Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2014-2019)
Table Millennium Pharmaceuticals Recent Development
Table Celgene Corporation Company Details
Table Celgene Corporation Revenue in Multiple Myeloma Therapeutics Business (2014-2019)(Million US$)
Figure Celgene Corporation Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2014-2019)
Table Celgene Corporation Recent Development
Table Kesios Therapeutics Limited Company Details
Table Kesios Therapeutics Limited Revenue in Multiple Myeloma Therapeutics Business (2014-2019)(Million US$)
Figure Kesios Therapeutics Limited Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2014-2019)
Table Kesios Therapeutics Limited Recent Development
Table Amgene, Inc. Company Details
Table Amgene, Inc. Revenue in Multiple Myeloma Therapeutics Business (2014-2019)(Million US$)
Figure Amgene, Inc. Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2014-2019)
Table Amgene, Inc. Recent Development
Table Genzyme Corporation Company Details
Table Genzyme Corporation Revenue in Multiple Myeloma Therapeutics Business (2014-2019)(Million US$)
Figure Genzyme Corporation Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2014-2019)
Table Genzyme Corporation Recent Development
Table Juno Therapeutics Company Details
Table Juno Therapeutics Revenue in Multiple Myeloma Therapeutics Business (2014-2019)(Million US$)
Figure Juno Therapeutics Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2014-2019)
Table Juno Therapeutics Recent Development
Table Global Multiple Myeloma Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Multiple Myeloma Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Multiple Myeloma Therapeutics Market Size Share by Regions in 2025
Figure United States Multiple Myeloma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Multiple Myeloma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Multiple Myeloma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Multiple Myeloma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Multiple Myeloma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Multiple Myeloma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Multiple Myeloma Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Multiple Myeloma Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Multiple Myeloma Therapeutics Market Size by Product (2019-2025)
Figure Global Multiple Myeloma Therapeutics Market Size by Product in 2025
Table Global Multiple Myeloma Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Multiple Myeloma Therapeutics Market Size by Application (2019-2025)
Figure Global Multiple Myeloma Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
多発性骨髄腫用るCAR T細胞療法の世界市場：市場規模・現状・予測 CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it i…- 多発性骨髄腫診断の世界市場：市場規模・現状・予測 Plasma cells help in fighting infection however, malignant plasma cells in multiple myeloma accumulate in the bone marrow, blocks the normal function of plasma cells. The M protein which is an abnormal antibody produced by malignant plasma cells cause tumors, bone destruction, kidney damage, and dam…
- 多発性硬化症向け幹細胞療法の世界市場：市場規模・現状・予測 Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision,…
- 鎌状赤血球病治療の世界市場：市場規模・現状・予測 Sickle Cell Disease (SCD) is a group of blood disorders typically inherited from a person's parents.The care of people with sickle cell disease may include infection prevention with vaccination and antibiotics, high fluid intake, folic acid supplementation and pain medication. In 2018, the global Si…
- 鎌状赤血球病治療の世界市場：市場規模・現状・予測 Sickle Cell Disease (SCD) is a group of blood disorders typically inherited from a person's parents.The care of people with sickle cell disease may include infection prevention with vaccination and antibiotics, high fluid intake, folic acid supplementation and pain medication. In 2018, the global Si…